Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert E Burrier

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Nature Biotechnology|September 7, 2018
Biocon's target factoryThomas X Neenan, Robert E Burrier, Sunghoon Kim
Molecular Aspects of Medicine|March 20, 2013
The ABCs of membrane transporters in health and disease (SLC series): introductionMatthias A Hediger, Benjamin Clémençon, Robert E Burrier, et al.
Biological Psychiatry|January 1, 2019
Reply to: Lack of Diagnostic Utility of "Amino Acid Dysregulation Metabotypes"Alan M Smith, Elizabeth L R Donley, Robert E Burrier, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|February 11, 2020
A Targeted Metabolomics-Based Assay Using Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Identifies Structural and Functional Cardiotoxicity PotentialJessica A Palmer, Alan M Smith, Vitalina Gryshkova, et al.
Frontiers in Psychiatry|November 6, 2023
Metabolomic biomarkers in autism: identification of complex dysregulations of cellular bioenergeticsAlan M Smith, Elizabeth L R Donley, Denise M Ney, et al.
Biological Psychiatry|November 18, 2018
Amino Acid Dysregulation Metabotypes: Potential Biomarkers for Diagnosis and Individualized Treatment for Subtypes of Autism Spectrum DisorderAlan M Smith, Joseph J King, Paul R West, et al.
Reproductive Toxicology (Elmsford, N.Y.)|July 27, 2017
A human induced pluripotent stem cell-based in vitro assay predicts developmental toxicity through a retinoic acid receptor-mediated pathway for a series of related retinoid analoguesJessica A Palmer, Alan M Smith, Laura A Egnash, et al.
Autism Research : Official Journal of the International Society for Autism Research|June 20, 2020
A Metabolomics Approach to Screening for Autism Risk in the Children's Autism Metabolome ProjectAlan M Smith, Marvin R Natowicz, Daniel Braas, et al.
Birth Defects Research. Part B, Developmental and Reproductive Toxicology|October 15, 2013
Establishment and assessment of a new human embryonic stem cell-based biomarker assay for developmental toxicity screeningJessica A Palmer, Alan M Smith, Laura A Egnash, et al.
Plos One|November 8, 2014
Metabolomics as a tool for discovery of biomarkers of autism spectrum disorder in the blood plasma of childrenPaul R West, David G Amaral, Preeti Bais, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Nature Biotechnology|September 7, 2018
Biocon's target factoryThomas X Neenan, Robert E Burrier, Sunghoon Kim
Molecular Aspects of Medicine|March 20, 2013
The ABCs of membrane transporters in health and disease (SLC series): introductionMatthias A Hediger, Benjamin Clémençon, Robert E Burrier, et al.
Biological Psychiatry|January 1, 2019
Reply to: Lack of Diagnostic Utility of "Amino Acid Dysregulation Metabotypes"Alan M Smith, Elizabeth L R Donley, Robert E Burrier, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|February 11, 2020
A Targeted Metabolomics-Based Assay Using Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Identifies Structural and Functional Cardiotoxicity PotentialJessica A Palmer, Alan M Smith, Vitalina Gryshkova, et al.
Frontiers in Psychiatry|November 6, 2023
Metabolomic biomarkers in autism: identification of complex dysregulations of cellular bioenergeticsAlan M Smith, Elizabeth L R Donley, Denise M Ney, et al.
Biological Psychiatry|November 18, 2018
Amino Acid Dysregulation Metabotypes: Potential Biomarkers for Diagnosis and Individualized Treatment for Subtypes of Autism Spectrum DisorderAlan M Smith, Joseph J King, Paul R West, et al.
Reproductive Toxicology (Elmsford, N.Y.)|July 27, 2017
A human induced pluripotent stem cell-based in vitro assay predicts developmental toxicity through a retinoic acid receptor-mediated pathway for a series of related retinoid analoguesJessica A Palmer, Alan M Smith, Laura A Egnash, et al.
Autism Research : Official Journal of the International Society for Autism Research|June 20, 2020
A Metabolomics Approach to Screening for Autism Risk in the Children's Autism Metabolome ProjectAlan M Smith, Marvin R Natowicz, Daniel Braas, et al.
Birth Defects Research. Part B, Developmental and Reproductive Toxicology|October 15, 2013
Establishment and assessment of a new human embryonic stem cell-based biomarker assay for developmental toxicity screeningJessica A Palmer, Alan M Smith, Laura A Egnash, et al.
Plos One|November 8, 2014
Metabolomics as a tool for discovery of biomarkers of autism spectrum disorder in the blood plasma of childrenPaul R West, David G Amaral, Preeti Bais, et al.
Pageof 1